Lung Cancer Trial, Recruiting (NCT06623487)

Lung Cancer Trial, Recruiting NCT06623487 Sponsor: Ruijin Hospital Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06623487 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People diagnosed with stage III non-small cell lung cancer (a specific type and stage of lung cancer) who, based on standard medical guidelines, have been assessed as needing pre-surgery immune-based treatment
People who are able to give their full written agreement to take part after being informed about the trial
People who are able to follow the requirements of the trial as set out by the research team
People aged between 18 and 75 years old
People with a life expectancy of at least 6 months

Who may not be able to join:

People with serious health conditions that the trial doctor considers would make participation unsafe, such as severe heart or lung problems, severely reduced bone marrow function, or severe liver or kidney problems
People with a hole in the intestine (intestinal perforation) or a complete blockage of the intestine
People with diabetes that is not well controlled, or whose fasting blood sugar level measures 11 mmol/L or higher on the day of testing
Women who are pregnant, possibly pregnant, or currently breastfeeding
People who the trial team believes would have difficulty following the trial's requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06623487

Sponsor: Ruijin Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

More information: https://clinicaltrials.gov/study/NCT06623487

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People diagnosed with stage III non-small cell lung cancer (a specific type and stage of lung cancer) who, based on standard medical guidelines, have been assessed as needing pre-surgery immune-based treatment
People who are able to give their full written agreement to take part after being informed about the trial
People who are able to follow the requirements of the trial as set out by the research team
People aged between 18 and 75 years old
People with a life expectancy of at least 6 months

Who may not be able to join:

People with serious health conditions that the trial doctor considers would make participation unsafe, such as severe heart or lung problems, severely reduced bone marrow function, or severe liver or kidney problems
People with a hole in the intestine (intestinal perforation) or a complete blockage of the intestine
People with diabetes that is not well controlled, or whose fasting blood sugar level measures 11 mmol/L or higher on the day of testing
Women who are pregnant, possibly pregnant, or currently breastfeeding
People who the trial team believes would have difficulty following the trial's requirements

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Ruijin Hospital

Registry

ClinicalTrials.gov

Start date

19 July 2024

Est. completion

30 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Predictive performance 1

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov